Caprostat Injection
By Caprostat
Rx
5ml Injection in a Vial

Composition
Epsilon Aminocaproic Acid(NA)

Manufacturer - Life Sciences Inc
2900 72nd Street North, St. Petersburg, FL 33710 USA

Expires on or after
September, 2025

liver
Caprostat Injection is considered safe for use in individuals with liver disease based on the available data. It appears that adjusting the dosage of Caprostat Injection may not be necessary for patients with liver issues. However, it is strongly recommended to consult with your doctor before using Caprostat Injection to ensure the best course of action for your personal situation.

kidney
Caution should be taken when using Caprostat Injection in patients with kidney disease. It might require adjusting the dosage, so consult your doctor before administration.

alcohol
It is uncertain if it's safe to drink alcohol while using Caprostat Injection. It's advised to consult your doctor for guidance.

driving
It is not clear if Caprostat Injection affects driving ability. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Caprostat Injection may potentially harm the developing baby and should be used with caution during pregnancy. Limited human studies and animal testing have shown negative effects. Your doctor will assess the risks and benefits before prescribing this medication. Please consult your doctor.

breastfeeding
Safety advice regarding the use of Caprostat Injection during breastfeeding is not currently available. It is advisable to consult your healthcare provider for guidance.
Habit Forming | No |
Chemical Class | Medium-Chain Fatty Acids |
Therapeutic Class | BLOOD RELATED |
Action Class | Antifibrinolytic |
₹48.7
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 11-Feb-2025